The National Institutes of Health published a draft biosafety policy on September 14 that would replace its current Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. Public comments are open through October 19, 2026.

• NIH
• HHS
• Biosafety
• +3 more

USAspending.gov records show Leidos Biomedical Research Inc.'s non-competed NIH contract to run the Frederick National Laboratory for Cancer Research has obligated a cumulative $4.81 billion since 2008. The lab's operation is also the subject of a still-unresolved recompete fight.

• NIH
• HHS
• Leidos Biomedical Research
• +3 more